VERU Veru Inc
Company Analysis
Latest News
π΄ Veru is trading 5.2% down today amid broad biotech and market weakness
Veru is trading 5.2% down at $2.29, giving back part of yesterdayβs bounce as the stock tracks a broader market decline. β’ There are no fresh company-specific...
π΄ Veru is trading 5.1% down today on continued post-rally profit-taking
Veru is trading 5.1% down at $2.43 as investors continue to lock in gains following its recent Novo Nordisk clinical supply deal and strong Q2 fiscal 2026...
π΄ Veru is trading 5% down today on profit-taking after Novo Nordisk-driven rally
Veru is trading approximately 5% down today at $2.64 as the stock undergoes a period of consolidation following a recent rally fueled by a Novo Nordisk...
π΄ Veru is trading 5.2% down today on profit-taking after recent Novo Nordisk-driven rally
Veru is trading 5.2% down at $2.67 today as the stock undergoes profit-taking and consolidation following its recent sharp rally. β’ The previous multi-day...
π’ VERU is trading 5.5% up today, rebounding from a prior-session drop and after-hours momentum
VERU is trading 5.5% up at $2.81 as it rebounds from yesterday's decline and continues its after-hours momentum. β’ The stock is recovering from a 7.6% drop in...
π’ Veru Inc is trading 7.95% up in after-hours
VERU is trading at $2.87, up 7.95% in after-hours.
π΄ VERU extends move to 5.2% down
VERU is trading at $2.73, down 5.2% versus the comparison close of $2.88 during regular trading. This is a price-movement alert; no separate company-specific...
π΄ VERU is trading 6.25% down today amid continued volatility
VERU is trading at $2.70 (-6.25%) following a sharp early-session drop, which appears to be a continuation of recent volatility. β’ No major company-specific...
π’ Veru Inc is trading 6.39% up
VERU is trading at $3.33, up 6.39%.
π’ VERU is trading 6.3% up today, extending a rebound, also added to Russell Microcap Value Benchmark Index
VERU is trading at $3.20 (6.3% up), extending a rebound following its early-June spike on a Novo Nordisk clinical supply deal. β’ The company was added to the...
π΄ Veru Inc is trading 5% down today with no clear catalyst yet
Veru Inc is trading 5% down at $2.84 today, underperforming a broadly positive market backdrop despite a lack of fresh company-specific headlines. β’ The...
π΄ Veru Inc is trading 5.3% down today as it gives back part of last week's gains
Veru Inc is trading 5.3% down today at $2.96 as the stock retreats following a sharp rebound last week. β’ The decline occurred on light liquidity with no...
π΄ Veru Inc is trading 6.2% down today with no clear catalyst amid light pre-market liquidity
Veru Inc is trading 6.2% down at $2.94 in pre-market sessions with no clear catalyst for the move. β’ The decline gives back a portion of the June 15 rebound...
π’ Veru Inc is trading 5.2% up today, rebounding amid broad risk-on market sentiment
Veru Inc is trading 5.2% higher at $3.15, recovering a portion of last weekβs steep pullback following a Novo Nordisk-driven rally. β’ The move appears tied to...
π΄ Veru Inc is trading 5.4% down today on profit-taking after its recent Novo Nordisk-driven rally
Veru Inc is trading at $3.08 (-5.37%) as the stock faces profit-taking following a sharp rally tied to its clinical supply agreement with Novo Nordisk. β’ The...
π’ Veru Inc is trading 9% up today on its obesity-trial supply deal with Novo Nordisk
Veru Inc is trading at $3.21 (+8.98%) as shares continue to react to a clinical supply agreement with Novo Nordisk for the enobosarm obesity trial. * The...
π’ Veru Inc. trading 11.5% higher, continuing volatile week after Novo Nordisk agreement
Veru Inc. is trading 11.5% up at $3.29, continuing a period of high volatility following a major company announcement earlier in the week. β’ On June 4, Veru...
π’ Veru Inc is trading 10.34% up today as it rebounds from a two-day selloff following its Novo Nordisk deal surge
Veru Inc is trading at $3.31 (+10.34%) as it rebounds from a sharp two-day selloff following its June 4 surge tied to the Novo Nordisk supply agreement. β’ The...
π’ Veru Inc is trading 5% up today as it rebounds from a sharp pullback following its Novo Nordisk deal surge
Veru Inc is trading at $3.15 (5% up) as it stages a technical rebound following sharp declines that followed its June 4 surge on a Novo Nordisk supply...
π΄ Veru Inc is trading 5.3% down today as it extends a pullback following its recent surge
Veru Inc is trading at $2.84 (-5.33%) in pre-market as the stock continues to pull back from its massive June 4 rally. β’ The decline follows a period of...